Literature DB >> 10570514

[Treatment with chlorambucil of renal amyloidosis secondary to rheumatoid arthritis. Study of 6 cases].

N R Robles1, F Roncero, M Arrobas, J L Alvarez Vega, E Sánchez Casado.   

Abstract

BACKGROUND: Amyloidosis is a common complication of rheumatoid arthritis. Renal disease is the main manifestation and its usual outcome is the lost of renal function. Some clinical evidences suggest that low-dose treatment with chlorambucil may be effective as therapy of this complication. PATIENTS AND METHODS: The effect of chlorambucil treatment in a group of six patients diagnosed by renal biopsy of renal amyloidosis secondary to rheumatoid arthritis was evaluated. Patients were treated with 0.1 mg/kg body weight/day for a time above a year until reduction of proteinuria.
RESULTS: 3 out of 6 patients showed decrease of proteinuria below 500 mg/day, two patients have started renal replacement therapy and one died without response to treatment. It was detected non reversible azoospermia in one patient. Mean follow-up time has been sixty months.
CONCLUSIONS: Chlorambucil may be effective in the treatment of renal amyloidosis secondary to rheumatoid arthritis when treatment starts before renal function is impaired. Long term remissions can be obtained even after suspending treatment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10570514

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  1 in total

1.  Renal amyloidosis: an uncommon complication of juvenile idiopathic arthritis.

Authors:  Carolina Duarte; Clara Gomes; A Jorge Correia; Manuel Salgado
Journal:  Clin Rheumatol       Date:  2005-11-01       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.